Expertise in
16
conditions

Urs M. Fischer

Bern, BE, CH 
Expertise in
16
conditions
Bern, BE, CH 

Overview

Urs Fischer practices practicing medicine in Bern, Switzerland.

Fischer is highly rated in 16 conditions, according to our data. Their clinical expertise encompasses Stroke, Transient Ischemic Attack (TIA), Migraine with Brainstem Aura, Thrombectomy, and Craniectomy.

They are actively involved in clinical research, co-authoring 486 peer reviewed articles and participating in 8 clinical trials.

Locations

Bern, BE, Switzerland
Other Locations
Basel, BS 4031, Switzerland
Cantonal Hospital St. Gallen, St. Gallen All In Switzerland, Sankt Gallen, SG, Switzerland
Lugano, TI, Switzerland
St Gallen Cantonal Hospital, St Gallen
Switzerland

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive
Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT), Substudies: MRI, Cognitive
Enrollment Status: Completed
Publish Date: September 12, 2025
Intervention Type: Drug
Study Drugs: Telmisartan, Amlodipine, Indapamide
Study Phase: Phase 3
EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke - a prAgmatic, International, Multicentre, Randomized triaL (DISTAL)
EnDovascular Therapy Plus Best Medical Treatment (BMT) Versus BMT Alone for MedIum VeSsel Occlusion sTroke - a prAgmatic, International, Multicentre, Randomized triaL (DISTAL)
Enrollment Status: Active_not_recruiting
Publish Date: December 24, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Swiss Trial of Decompressive Craniectomy Versus Best Medical Treatment of Spontaneous Supratentorial Intracerebral Hemorrhage (SWITCH): a Randomized Controlled Trial
Swiss Trial of Decompressive Craniectomy Versus Best Medical Treatment of Spontaneous Supratentorial Intracerebral Hemorrhage (SWITCH): a Randomized Controlled Trial
Enrollment Status: Completed
Publish Date: November 14, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke
Solitaire™ With the Intention For Thrombectomy Plus Intravenous t-PA Versus DIRECT Solitaire™ Stent-retriever Thrombectomy in Acute Anterior Circulation Stroke
Enrollment Status: Completed
Publish Date: November 14, 2024
Intervention Type: Drug, Device
Study Phase: Not Applicable
Early Minimally Invasive Image Guided Endoscopic Evacuation of Intracerebral Haemorrhage: a Prospective Pilot Study
Early Minimally Invasive Image Guided Endoscopic Evacuation of Intracerebral Haemorrhage: a Prospective Pilot Study
Enrollment Status: Completed
Publish Date: August 15, 2024
Intervention Type: Procedure
Study Phase: Not Applicable
Endovascular Therapy vs Medical Management of PosterIor Cerebral Artery Occlusion Stroke
Endovascular Therapy vs Medical Management of PosterIor Cerebral Artery Occlusion Stroke
Enrollment Status: Completed
Publish Date: June 04, 2024
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
MidregiOnal Proatrial Natriuretic Peptide to Guide SEcondary Stroke Prevention: The MOSES-study. An International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Unknown
Publish Date: August 16, 2023
Intervention Type: Drug
Study Drugs: Dabigatran, Apixaban, Edoxaban, Aspirin, Clopidogrel
Study Phase: Phase 3
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Early Versus Late Initiation of Direct Oral Anticoagulants in Post-ischaemic Stroke Patients With Atrial fibrillatioN (ELAN): an International, Multicentre, Randomised-controlled, Two-arm, Assessor-blinded Trial
Enrollment Status: Completed
Publish Date: July 18, 2023
Intervention Type: Drug
Study Phase: Not Applicable
View 7 Less Clinical Trials

486 Total Publications

Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis.
Colchicine for Secondary Prevention After Stroke According to the Presence of Atherosclerosis.
Journal: Stroke
Published: August 20, 2026

Frequently Asked Questions about Urs M. Fischer

Is Urs M. Fischer a top-rated expert for Stroke?

MediFind is an objective health platform that identifies experts based on real-world data. Urs M. Fischer is classified as an Elite expert for Stroke, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Urs M. Fischer participate in research or clinical trials?

Yes. Urs M. Fischer has published 486 articles and abstracts on conditions like Stroke. You can view a list of Urs M. Fischer's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Fischer's expertise for a condition
ConditionClose
View All 10 Advanced Conditions
View All 33 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile